NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
Clinical Trials
40 trialsNCT04853914 2025-06-05
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
EDAP TMS S.A.
Phase NA Completed
NCT06726070 2024-12-10
Investigation of the Diagnostic Role of miRNAs in PCa and BPH
Alanya Alaaddin Keykubat University
Completed
NCT03350529 2024-11-25
HIFU-PRO
Turku University Hospital
Phase NA Completed
NCT04693507 2024-07-23
TEACh
Antev Ltd.
Phase 2 Completed
NCT06380062 2024-04-25
Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia
Universität des Saarlandes
Completed
NCT05314582 2023-07-28
Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia
Bezmialem Vakif University
Completed
NCT05834270 2023-04-28
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Menoufia University
Phase NA Completed
NCT05506735 2022-08-19
PSA
University of Baghdad
Completed
NCT04446429 2021-12-10
Anti-Androgen Treatment for COVID-19
Applied Biology, Inc.
Phase NA Completed
NCT02425800 2021-09-01
Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells
Wake Forest University Health Sciences
Completed
NCT04962269 2021-07-14
Application of DWI in Diagnosis of Prostate Cancer
Peking University Third Hospital
Completed
NCT04212403 2020-02-24
Prophylaxis001
Jessa Hospital
Phase NA Completed
NCT01446991 2020-01-27
Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy
British Columbia Cancer Agency
Phase 2 Completed
NCT02873117 2018-02-26
CANARI
Rennes University Hospital
Completed
NCT02916537 2017-11-06
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057
Cancer Targeted Technology
Phase 1 Completed
NCT00632905 2017-09-28
BHOS
CMX Research
Completed
NCT02167919 2017-09-14
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
University of North Carolina, Chapel Hill
Phase NA Completed
NCT00883909 2017-07-11
ARI103094-Follow-Up Study for REDUCE Study Subjects
GlaxoSmithKline
Completed
NCT02778243 2017-06-14
STERPROSER
Hopital Foch
Phase NA Completed
NCT01337258 2017-05-30
Economic Analyses of the REDUCE Trial
GlaxoSmithKline
Completed
NCT01371513 2017-05-22
RESPECT
GlaxoSmithKline
Completed
NCT03009123 2017-05-09
EDtoPC
Kuang Tien General Hospital
Completed
NCT00375765 2017-01-19
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
GlaxoSmithKline
Phase 4 Completed
NCT01767363 2016-11-09
WEUSKOP5723: Prostate Cancer Study
GlaxoSmithKline
Completed
NCT02846467 2016-08-10
Information Improvement for Surgical Patients Through Portable Video Media
Hospital Universitario Puerto Real
Phase NA Completed
NCT02015806 2016-01-11
REMIND
Brigham and Women's Hospital
Phase NA Completed
NCT01826617 2015-04-07
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
St. Luke's Medical Center, Philippines
Completed
NCT01886547 2015-04-07
2013 Annual National Digital Rectal Exam (DRE) Day Study
St. Luke's Medical Center, Philippines
Completed
NCT01177436 2014-08-29
Prostate Cancer Antigen 3 (PCA-3) Gene Project
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT01665586 2014-07-28
Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study
Yonsei University
Phase NA Completed
NCT01678313 2014-07-15
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Buddhist Tzu Chi General Hospital
Phase 2 Completed
NCT00822952 2014-03-31
PMI
Artann Laboratories
Completed
NCT00706966 2014-01-17
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
University of California, San Francisco
Phase NA Completed
NCT00416390 2013-09-20
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
National Cancer Institute (NCI)
Phase NA Completed
NCT00632138 2013-08-07
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
National Cancer Institute (NCI)
Phase 3 Completed
NCT01218243 2013-05-27
An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 2 Completed
NCT00978991 2013-02-08
Duke Urology Database and Specimen Bank
Duke University
Completed
NCT00426777 2012-02-03
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
CMX Research
Phase 3 Completed
NCT01250483 2010-11-30
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
Seoul National University Hospital
Completed